Why Preventive Medicine Still Feels Stuck—and Why It Doesn’t Have to Be

Estimated read time: ~7 min

Summary:

• Preventive medicine hasn’t kept pace with scientific progress because the healthcare system was built around acute, volume‑based care—not long‑term health.
• Financial incentives, training models, and regulation reinforce inertia, making prevention harder to deliver despite strong evidence.
• Digital tools like telehealth, remote monitoring, and wearables work, improving chronic disease outcomes and preventive care when implemented thoughtfully.
• The real challenge is redesigning care delivery

Medicine has changed dramatically over the past few decades. We can detect disease earlier, monitor health continuously, and personalize care in ways that would have been unimaginable not long ago. And yet, for most people, the experience of outpatient preventive care feels largely the same.

You schedule an appointment weeks out. You get a short visit. You’re told to “work on lifestyle,” and then you’re mostly on your own until the next check‑in. The science has moved forward—but the system delivering that science hasn’t kept up.

This gap isn’t because clinicians don’t care or because the tools don’t work. It’s because the healthcare system was never designed around prevention—and changing it has proven harder than expected.

Outpatient medicine didn’t always operate on rigid schedules and standardized visits. Earlier models allowed for more flexibility and individualized care. Over time, as healthcare consolidated into larger systems, efficiency and standardization took priority. Appointments became fixed blocks of time, scheduling became centralized, and care became increasingly transactional.¹

Medical education followed a similar trajectory. Training has historically emphasized acute, hospital‑based care rather than long‑term prevention and behavior change. Most medical schools and residencies don’t have mandatory lifestyle medicine training, despite a healthy lifestyle being the foundation for longevity. Even as society and technology evolved, curricula were slow to adapt, reinforcing a system optimized for reacting to disease rather than preventing it.²

Once systems like this are established, they tend to resist change. Dominant medical models often accept only incremental reform unless pushed by external forces.³ That resistance still shapes outpatient care today.

The financial structure of healthcare plays a major role in this inertia. In the U.S., most outpatient care is still reimbursed through fee‑for‑service models, which reward volume rather than outcomes. Time spent on prevention, education, or proactive monitoring often isn’t reimbursed—or is reimbursed poorly—making it difficult to prioritize.⁴

Primary care remains underfunded relative to its importance, accounting for a small share of total healthcare spending.⁵ Meanwhile, administrative complexity and regulatory burden further limit flexibility and innovation.⁶ The result is a system that excels at treating problems once they appear, but struggles to invest in keeping people healthy in the first place.

Clinical inertia—the tendency to delay or avoid changes in care even when evidence supports them—is common in outpatient medicine.⁷ This isn’t a failure of individual clinicians. It reflects time pressure, fragmented workflows, patient hesitation, and lack of organizational support.

Cultural expectations also matter. Many clinicians were trained in more paternalistic models of care, while many patients still expect healthcare to be something that happens to them rather than with them. Shifting toward shared decision‑making and prevention‑focused care requires both mindset change and structural support.

Even when clinicians want to innovate, regulatory barriers can slow progress. Telehealth adoption, for example, has been shaped by inconsistent licensure rules, reimbursement policies, and privacy requirements.⁸⁻⁹ Temporary expansions during the COVID‑19 pandemic demonstrated what’s possible—but long‑term policy stability remains uncertain.

Access issues compound the problem. Not everyone has reliable broadband, digital literacy, or comfort with technology. These gaps disproportionately affect rural communities, older adults, and underserved populations, raising legitimate concerns about equity if better preventive medicine were to be engineered through digital technologies.¹⁰

Despite these challenges, the evidence supporting digital approaches to preventive care is compelling. Telehealth has consistently been shown to improve outcomes for chronic conditions like hypertension and diabetes, with reductions in blood pressure and HbA1c compared to usual care.¹¹⁻¹² Large real‑world studies also show higher rates of preventive screenings, chronic disease monitoring, and quality measures among patients who use telemedicine.¹³

Remote patient monitoring extends care beyond the clinic by allowing clinicians to track health data between visits. Systematic reviews show improvements in chronic disease outcomes and reductions in hospital utilization for selected populations.¹⁴⁻¹⁵ While results depend on patient selection and workflow integration, the potential is clear.

Wearable devices add another layer. Activity trackers reliably increase physical activity, while tools like continuous glucose monitors help patients understand how daily choices affect their health in real time.¹⁶ These tools don’t replace clinicians—but they give patients better feedback and more agency.

If the evidence is strong, why hasn’t adoption moved faster? Because technology alone doesn’t change systems. People, workflows, and incentives do.

The programs that actually work don’t just introduce new tools and hope for the best. They invest in training, redesign workflows, identify clinical champions, and build in regular feedback. High‑touch approaches consistently outperform low‑touch ones, especially in real‑world clinical settings. Hybrid models—where digital tools support care without replacing in‑person visits—tend to work best, preserving hands‑on care where it truly matters.

Large healthcare organizations are rarely the first to make these kinds of changes. For established systems, meaningful innovation carries financial and operational risk. As a result, much of the experimentation needed to move outpatient medicine forward has fallen to smaller organizations and startups—groups that are more willing to test new models, accept uncertainty, and challenge long‑standing assumptions about how care should be delivered.

delaeMD was built in response to the exact problems outlined above. The traditional outpatient model struggles with prevention because it was never designed for it. Short visits, reactive care, misaligned incentives, and fragmented follow‑up make it difficult to support long‑term health—no matter how motivated clinicians or patients may be. delaeMD starts from a different premise: that prevention works best when care is continuous, collaborative, and designed around real life rather than clinic schedules.

At its core, delaeMD is a telehealth‑first healthspan medicine practice focused on keeping people healthy longer—not just treating disease once it appears. Instead of relying on episodic visits, care is structured around ongoing relationships with a dedicated physician, supported by remote monitoring, longitudinal data, and regular touchpoints that extend beyond the traditional appointment.

This model directly addresses many of the structural barriers discussed earlier. Telehealth removes geographic friction and allows care to happen the moment its needed (ie. when remote health monitoring data starts to “drift”), not just when a clinic slot is available. Remote monitoring and wearable data provide insight into what’s happening between visits, where most health decisions are actually made. And longer‑term physician partnerships create space for education, shared decision‑making, and behavior change—elements that are often squeezed out of conventional care.

Just as importantly, delaeMD is designed to align incentives with outcomes. By focusing on prevention, metabolic health, and early risk identification, the goal is to reduce downstream disease burden rather than generate more visits or procedures. This allows clinicians to spend time where it matters most: helping patients understand their health, make informed choices, and adjust course over time.

delaeMD also reflects a broader reality about innovation in healthcare. Large systems, constrained by legacy infrastructure and financial risk, are rarely positioned to experiment with new delivery models. Smaller, physician‑led organizations have more flexibility to test, iterate, and refine approaches that challenge the status quo. delaeMD operates in that space—willing to rethink how outpatient medicine is delivered, while remaining grounded in evidence and clinical rigor.

In many ways, delaeMD isn’t proposing something radical. It’s applying what we already know works—continuity, prevention, patient engagement, and data‑informed care—within a system intentionally designed to support those goals. The technology enables it, but the philosophy drives it.

If preventive medicine is going to move forward, it won’t be by adding more tools to a broken structure. It will come from building care models that finally align how medicine is delivered with what medicine already knows how to do. delaeMD is one attempt to do exactly that.

1. Nguyen MT, Schotland SV, Howell JD. Ann Intern Med. 2022;175(10):1468‑1474.
2. Jones R, Higgs R, de Angelis C, Prideaux D. Lancet. 2001;357(9257):699‑703.
3. Garrison RL. J Fam Pract. 1995;40(3):281‑287.
4. Saini V, Garcia‑Armesto S, Klemperer D, et al. Lancet. 2017;390(10090):178‑190.
5. Levine DM, Linder JA, Landon BE. JAMA Intern Med. 2016;176(12):1778‑1790.
6. Fineberg HV. N Engl J Med. 2012;366(11):1020‑1027.
7. Lavoie KL, Rash JA, Campbell TS. Annu Rev Pharmacol Toxicol. 2017;57:263‑283.
8. Curfman A, Hackell JM, Herendeen NE, et al. Pediatrics. 2022;149(3):e2021056035.
9. Takahashi EA, Schwamm LH, Adeoye OM, et al. Circulation. 2022;146(25):e558‑e568.
10. Birati Y, Tzemah‑Shahar R. J Med Internet Res. 2026;28:e75591.
11. Kelly FA, Moraes FCA, Lôbo AOM, et al. J Telemed Telecare. 2025;31(10):1382‑1400.
12. Mabeza RMS, Maynard K, Tarn DM. BMC Prim Care. 2022;23(1):52.
13. Baughman DJ, Jabbarpour Y, Westfall JM, et al. JAMA Netw Open. 2022;5(9):e2233267.
14. Leo DG, Buckley BJR, Chowdhury M, et al. J Med Internet Res. 2022;24(11):e35508.
15. Smedslund G, Østerås N, Hestevik CH. JMIR mHealth uHealth. 2025;13:e68464.
16. Brickwood KJ, Watson G, O’Brien J, Williams AD. JMIR mHealth uHealth. 2019;7(4):e11819.
17. Miller DP Jr, Weaver KE, Case LD, et al. JAMA Intern Med. 2022;182(3):312‑320.